Sign in

NCT04469426Completed

Interactive Online Informational and Peer Support App for Patients with Low Anterior Resection Syndrome

Interactive Online Informational and Peer Support App for Patients with Low Anterior Resection Syndrome (LARS): a Multicenter Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 29 Nov 2024

Brief summary (registry, in English)

After surgery for rectal cancer, many people undergo changes in bowel habits, which may include the need to empty their bowels more often, accidental leakage of stool or gas, the sudden urge to go to the bathroom, and more. The term "Low Anterior Resection Syndrome" or LARS is used to describe these symptoms. LARS has a negative impact on one's quality of life, and can lead to frustration, as there is no single intervention that has proven to be effective for LARS, and each patient has to undergo trial and error to find one's solution. As people struggle with LARS, they describe feeling hopeless and isolated. Peer support is a supportive relationship between individuals who share common experiences or face similar challenges. The goal of our study is to evaluate whether use of an online peer support application with trained mentors who themselves have lived or are living with LARS will empower patients to better manage their LARS symptoms and improve their quality of life.

Status (registry)
Completed
Study type
Interventional
Enrollment
101 (actual)
First submitted
23 Mar 2020
Start date
15 Aug 2020
Primary completion date
31 Oct 2022
Lead sponsor
Jewish General Hospital
NCT number
NCT04469426

What you commit to

  • Study type: Interventional
  • Participants enrolled: 101
  • From 15 Aug 2020 to the primary completion date, 31 Oct 2022
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Active chemotherapy or radiotherapy
  • Major colonic resection in addition to protectomy

Other

  • Cannot be contacted by telephone
  • Unable to read and comprehend English/French
  • Does not have the appropriate interface to access the app
  • Unable to give clear and informed consent

Who the study is looking for

  • underwent restorative protectomy for Neo-plastic disease of the rectum
  • completed all treatment within the last 3 years
  • patients with minor or major LARS as defined with the LARS score.

Age in the registry: 18 years to 100 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
McGill University Health Centre
Coordinator of this site? Confirm its status
MontrealCanadaUnknown status
Jewish General Hospital
Coordinator of this site? Confirm its status
MontrealCanadaUnknown status
Mount Sinai Hospital
Coordinator of this site? Confirm its status
TorontoCanadaUnknown status
University Health Network
Coordinator of this site? Confirm its status
TorontoCanadaUnknown status
St. Paul's Hospital
Coordinator of this site? Confirm its status
VancouverCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.